Literature DB >> 22037127

Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder.

Charles R Conway1, Yvette I Sheline, John T Chibnall, Richard D Bucholz, Joseph L Price, Sunil Gangwani, Mark A Mintun.   

Abstract

BACKGROUND: Existing neuroimaging studies of vagus nerve stimulation (VNS) in treatment resistant major depression (TRMD) suggest that many brain regions (eg, prefrontal cortex, thalamus, cingulate cortex, insular cortex) associated with mood disorders undergo alterations in blood flow/metabolism. OBJECTIVE/HYPOTHESIS: Positron emission tomography (PET oxygen-15 labeled water or PET [(15)O] H(2)O) was used to identify changes in regional cerebral blood flow (rCBF) in response to immediate VNS in 13 subjects with TRMD. We hypothesized rCBF changes along the afferent pathway of the vagus and in regions associated with depression (eg, orbitofrontal cortex, amygdala, insular cortex).
METHODS: Six 90-second PET [(15)O] H(2)O scans were performed on 13 subjects in a VNS off-on sequence. After normalization for global uptake and realignment to standard atlas space, statistical t images (P < .005) were used to evaluate rCBF change.
RESULTS: VNS induced significant rCBF decreases in the left and right lateral orbitofrontal cortex and left inferior temporal lobe. Significant increases were found in the right dorsal anterior cingulate, left posterior limb of the internal capsule/medial putamen, the right superior temporal gyrus, and the left cerebellar body. Post hoc analysis found small-to-moderate correlations between baseline acute change in rCBF and antidepressant response after 12 months of VNS.
CONCLUSIONS: Regions undergoing rCBF change in response to acute VNS are consistent with the known afferent pathway of the vagus nerve and models of brain network in depression. Larger studies assessing the correlation between acute stimulation patterns and antidepressant outcomes with VNS are needed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037127      PMCID: PMC3270206          DOI: 10.1016/j.brs.2011.03.001

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  39 in total

1.  An autoradiographic examination of the central distribution of the trigeminal, facial, glossopharyngeal, and vagal nerves in the monkey.

Authors:  R M Beckstead; R Norgren
Journal:  J Comp Neurol       Date:  1979-04-01       Impact factor: 3.215

2.  Acute vagus nerve stimulation using different pulse widths produces varying brain effects.

Authors:  Qiwen Mu; Daryl E Bohning; Ziad Nahas; John Walker; Berry Anderson; Kevin A Johnson; Stewart Denslow; Mikhail Lomarev; Poya Moghadam; Jeong-Ho Chae; Mark S George
Journal:  Biol Psychiatry       Date:  2004-04-15       Impact factor: 13.382

3.  The trigeminal, facial, vagal, and glossopharyngeal nerves in the monkey. Afferent connections.

Authors:  A L Rhoton; J L O'Leary; J P Ferguson
Journal:  Arch Neurol       Date:  1966-05

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

6.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

7.  Brainstem projections of sensory and motor components of the vagus nerve in the rat.

Authors:  M Kalia; J M Sullivan
Journal:  J Comp Neurol       Date:  1982-11-01       Impact factor: 3.215

8.  The nucleus of the solitary tract in the monkey: projections to the thalamus and brain stem nuclei.

Authors:  R M Beckstead; J R Morse; R Norgren
Journal:  J Comp Neurol       Date:  1980-03-15       Impact factor: 3.215

Review 9.  Therapeutic mechanisms of vagus nerve stimulation.

Authors:  Thomas R Henry
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

10.  Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects.

Authors:  Mikhail Lomarev; Stewart Denslow; Ziad Nahas; Jeong-Ho Chae; Mark S George; Daryl E Bohning
Journal:  J Psychiatr Res       Date:  2002 Jul-Aug       Impact factor: 4.791

View more
  29 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats.

Authors:  Teruyuki Hiraki; Wesley Baker; Joel H Greenberg
Journal:  J Neurosci Res       Date:  2012-04       Impact factor: 4.164

3.  Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder.

Authors:  Grazyna Rajkowska; Jonathan Hughes; Craig A Stockmeier; Jose Javier Miguel-Hidalgo; Dorota Maciag
Journal:  Biol Psychiatry       Date:  2012-11-10       Impact factor: 13.382

4.  Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Authors:  Charles R Conway; John T Chibnall; Sunil Gangwani; Mark A Mintun; Joseph L Price; Tamara Hershey; Luis A Giuffra; Richard D Bucholz; Jon J Christensen; Yvette I Sheline
Journal:  J Affect Disord       Date:  2012-03-05       Impact factor: 4.839

5.  Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson's Disease.

Authors:  Ying Jiang; Zhentang Cao; Huizi Ma; Guihong Wang; Xuemei Wang; Zhan Wang; Yaqin Yang; Huiqing Zhao; Genliang Liu; Longling Li; Tao Feng
Journal:  Neurochem Res       Date:  2018-10-11       Impact factor: 3.996

6.  Transcutaneous Vagus Nerve Stimulation Modulates Default Mode Network in Major Depressive Disorder.

Authors:  Jiliang Fang; Peijing Rong; Yang Hong; Yangyang Fan; Jun Liu; Honghong Wang; Guolei Zhang; Xiaoyan Chen; Shan Shi; Liping Wang; Rupeng Liu; Jiwon Hwang; Zhengjie Li; Jing Tao; Yang Wang; Bing Zhu; Jian Kong
Journal:  Biol Psychiatry       Date:  2015-04-02       Impact factor: 13.382

Review 7.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

8.  L-PGDS Mediates Vagus Nerve Stimulation-Induced Neuroprotection in a Rat Model of Ischemic Stroke by Suppressing the Apoptotic Response.

Authors:  Lina Zhang; Jingxi Ma; Xinhao Jin; Gongwei Jia; Ying Jiang; Changqing Li
Journal:  Neurochem Res       Date:  2016-11-29       Impact factor: 3.996

9.  Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: A nonrandomized controlled pilot study.

Authors:  Peijing Rong; Jun Liu; Liping Wang; Rupeng Liu; Jiliang Fang; Jingjun Zhao; Yufeng Zhao; Honghong Wang; Mark Vangel; Sharon Sun; Hui Ben; Joel Park; Shaoyuan Li; Hong Meng; Bing Zhu; Jian Kong
Journal:  J Affect Disord       Date:  2016-02-10       Impact factor: 4.839

Review 10.  Vagal Nerve Stimulation for Treatment-Resistant Depression.

Authors:  Flavia R Carreno; Alan Frazer
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.